Two studies report on thoracic radiotherapy for lung cancer: a phase III trial found adding radiotherapy to chemoimmunotherapy did not improve survival in extensive-stage small cell lung cancer, while a retrospective review showed high local control rates with single-fraction 28 Gy stereotactic body radiotherapy.
WHO in January 2024 launched its first list of priority childhood cancer drug formulations, naming six medicines that still lack optimal child-friendly versions. The agency says about 400,000 children and adolescents develop cancer each year and is working to expand access to safe, effective paediatric formulations.
New research demonstrates blood-based biomarkers can predict testicular cancer recurrence and treatment outcomes, while separate study reveals long-term health risks vary by chemotherapy regimen in survivors.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06712355 |
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer |
RECRUITING | PHASE3 |
| NCT06646276 |
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS). |
RECRUITING | PHASE3 |
| NCT06406465 |
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity |
RECRUITING | PHASE2 |
| NCT05389423 |
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas |
RECRUITING | PHASE1 |
| NCT04139304 |
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma |
RECRUITING | EARLY_PHASE1 |
| NCT03811002 |
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) |
ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00092222 |
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity |
ACTIVE_NOT_RECRUITING | PHASE2 |
